Researchers’ Perceptions of the Ethical Implications of Pharmacogenomics Research with Children
Authors:
- D. AvardDAD. Avard
- T. SilversteinTST. Silverstein
- G. SillonGSG. Sillon
- Y. JolyYJY. Joly
- 1 February 2009
- journal article
- research article
- Published by S. Karger AG in Public Health Genomics
- Vol. 12 (3) , 191-201
Abstract
Background: This paper presents the results of an exploratory qualitative study that assesses Canadian pediatric researchers’ perceptions of a pre-selected group of ethical issues raised by pharmacogenomics research with children. Methods: As a pilot study, we conducted semi-structured telephone interviews with Canadian pediatric pharmacogenomic researchers. The interviews were guided by the following themes: (1) benefits and risks of inclusion, (2) the consent/assent process, and (3) the return of research results. Results: Issues about assent, consent, risks and benefits, as well as the communication of results were addressed by the respondents. Some issues, such as the unique vulnerability of children, the long term privacy concerns associated with biobanking, additional core elements that need to be discussed and included in the consent/assent forms, as well as the challenges of communicating research results in a pediatric research were not explicitly identified by the respondents. Conclusion: Further consideration should be given to address the ethical challenges of including children in pharmacogenomics research. This exploratory study indicates that further guidance is needed if children are to be protected and yet benefit from such research.Keywords
This publication has 39 references indexed in Scilit:
- An ethical and legal overview of pharmacogenomics: perspectives and issues.2008
- Incidental Findings in Pediatric ResearchJournal of Law, Medicine & Ethics, 2008
- Ancillary risk information and pharmacogenetic tests: social and policy implicationsThe Pharmacogenomics Journal, 2007
- The emergence of an ethical duty to disclose genetic research results: international perspectivesEuropean Journal of Human Genetics, 2006
- Pharmacogenomic Data Sample Collection and Storage: Ethical Issues and Policy ApproachesPharmacogenomics, 2006
- Ensuring Safe and Effective Medications for ChildrenJAMA, 2003
- Pharmacogenomics and ChildrenAmerican Journal of PharmacoGenomics, 2003
- Ethical dimensions of genetics in pediatric neurology: A look into the futureSeminars in Pediatric Neurology, 2002
- Incidence of adverse drug reactions in paediatric in/out‐patients: a systematic review and meta‐analysis of prospective studiesBritish Journal of Clinical Pharmacology, 2001
- Ethics and Clinical ResearchNew England Journal of Medicine, 1966